These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 9388846)

  • 1. [The effect of salmeterol on the activity of neutrophil chemotactic factor in patients with asthma].
    Kong L; Li Z; Yu R
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):88-90. PubMed ID: 9388846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.
    Campbell LM; Anderson TJ; Parashchak MR; Burke CM; Watson SA; Turbitt ML
    Respir Med; 1999 Jul; 93(7):236-44. PubMed ID: 10464829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
    Kishimoto N; Ohnishi H; Fujita J; Kamei T; Tada S; Ueda N
    Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmeterol compared with current therapies in chronic asthma.
    Adinoff AD; Schwartz HJ; Rickard KA; Yancey SW; Swearingen BE
    J Fam Pract; 1998 Oct; 47(4):278-84. PubMed ID: 9789513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
    Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
    Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
    J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
    Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
    Chazan R; Grubek-Jaworska H; Hermanowicz-Salomon J; Droszcz W
    Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol: a long-acting beta 2-agonist.
    D'Alonzo GE; Tolep K
    J Am Osteopath Assoc; 1998 Apr; 98(4):216-8, 221-31. PubMed ID: 9594486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmeterol for nocturnal asthma.
    Bryan S
    J Fam Pract; 1999 Jun; 48(6):415-6. PubMed ID: 10386478
    [No Abstract]   [Full Text] [Related]  

  • 12. Salmeterol therapy in mild asthma.
    Weaving PG
    Br J Gen Pract; 1991 Aug; 41(349):346. PubMed ID: 1685661
    [No Abstract]   [Full Text] [Related]  

  • 13. Salmeterol therapy in mild asthma.
    Hyland ME; Jones KP
    Br J Gen Pract; 1991 Sep; 41(350):387. PubMed ID: 1686556
    [No Abstract]   [Full Text] [Related]  

  • 14. Salmeterol in children.
    Br J Hosp Med; 1991 Nov; 46(5):344. PubMed ID: 1683591
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of cardiorespiratory effects of procaterol and salbutamol in asthmatic patients.
    Youngchaiyud P
    J Med Assoc Thai; 1982 Feb; 65(2):86-94. PubMed ID: 6122706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-allergic effects of beta-adrenoceptor agonists in the clinical pharmacological studies].
    Horikoshi S; Kokubu F; Adachi M
    Nihon Rinsho; 1996 Nov; 54(11):3068-72. PubMed ID: 8950956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of procaterol and salbutamol in patients with bronchial asthma].
    Płusa T; Zaraś E; Kruszewski J
    Pneumonol Alergol Pol; 1992; 60(11-12):48-52. PubMed ID: 1303778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediators of hypersensitivity in exercise-induced asthma.
    Kay AB; Lee TH
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():237-41. PubMed ID: 6352303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmeterol for emphysema?
    Healey D
    Aust Fam Physician; 1996 Aug; 25(8):1340. PubMed ID: 8771895
    [No Abstract]   [Full Text] [Related]  

  • 20. [Salmeterol no longer banned in Olympic Games].
    van Dam JG
    Ned Tijdschr Geneeskd; 1996 Aug; 140(31):1612. PubMed ID: 8768818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.